黑色素分泌和2型糖尿病的发生率
Ciaran J McMullan1, Eva S Schernhammer, Eric B Rimm
1Renal Division, Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA. cmcmullan1@partners.org
JAMA
|April 4, 2013
概括
较低的黑激素分泌与增加2型糖尿病风险有关. 这项研究发现,拥有较少黑激素的女性患糖尿病的几率明显更高.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 时间生物学 时间生物学
背景情况:
- 黑色素受体功能丧失突变与胰岛素抵抗和2型糖尿病有关.
- 较低的夜间黑激素分泌与在没有糖尿病的个体中增加的胰岛素抵抗有关.
研究的目的:
- 调查黑激素分泌水平与随后患2型糖尿病的风险之间的关联.
主要方法:
- 在护士健康研究队列中进行了一项病例控制研究.
- 在2000年至2012年期间,有370名患有2型糖尿病的妇女与370名没有糖尿病的对照进行了匹配,这些对照是基于2000年的基线尿液和血液样本.
- 多变量条件后勤回归被用于分析关联,控制各种人口,生活方式,睡眠质量,炎症和内皮功能障碍因素.
主要成果:
- 尿液中6 - 硫胺与肌素比率较低的女性表现出2型糖尿病的风险增加.
- 患上2型糖尿病的多变量几率比为2.17 (95% CI,1.18-3.98) 在较低的黑激素分泌类别的女性与最高的女性相比.
- 糖尿病发病率是4.27例/1000人/年在最高的黑激素分泌组,而9.27例/1000人/年在最低的.
结论:
- 降低黑激素分泌独立地与患2型糖尿病的风险增加有关.
- 建议进行进一步的研究,以确定黑色素分泌是否是一般人群中2型糖尿病的可修改风险因素.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...


